These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 2643240

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cytoprotection of gastroduodenal mucous membrane with analogues of prostaglandins.
    Lauritsen K, Laursen LS, Rask-Madsen J.
    Recenti Prog Med; 1989 Jun; 80(6):344-52. PubMed ID: 2672199
    [Abstract] [Full Text] [Related]

  • 4. [Drug therapy of peptic ulcer. What is coming up?].
    Müller P, Dammann HG, Simon B, Kommerell B.
    Leber Magen Darm; 1987 Feb; 17(1):50-4. PubMed ID: 3104707
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G, Hopkins A, Akbar FA.
    Postgrad Med J; 1988 Feb; 64 Suppl 1():60-77. PubMed ID: 3138682
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
    Thomson AB, Mahachai V.
    Clin Invest Med; 1987 May; 10(3):152-70. PubMed ID: 2887321
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD.
    Yale J Biol Med; 1996 May; 69(3):211-24. PubMed ID: 9165690
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prostaglandins in clinical treatment of gastroduodenal mucosal lesions: a review.
    Aly A.
    Scand J Gastroenterol Suppl; 1987 May; 137():43-9. PubMed ID: 3321405
    [Abstract] [Full Text] [Related]

  • 12. Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.
    Goa KL, Monk JP.
    Drugs; 1987 Nov; 34(5):539-59. PubMed ID: 3121276
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of protective drugs in the prevention of ulcer relapse.
    Ota S, Terano A.
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.